Skip to content
About
The Committee
The Chair
The Ranking Member
Membership
Subcommittees
Committee Rules
Clerkships
Committee Activity
Hearings
Oversight
Legislation
Committee Documents
Nominations
Executive Nominations
Judicial Nominations
Supreme Court
Confirmed Nominations
Latest News
Majority Press
Minority Press
Press Kit
Website Search Open
Submit Site Search Query
Website Search
Senator Facebook
Twitter
Instagram
Home Logo Link
Committee Activity
Hearings
Full Committee
Examining the Senate and House Versions of the 'Greater Access to Affordable Pharmaceuticals Act'
Type:
Full Committee Hearing
Date:
Friday, August 1st, 2003
Time:
09:30am
Location:
SD-226
There is no video broadcast for this event.
Member Statements
Senator
Orrin G. Hatch
R, UT
Hatch Member Statement 080103
Senator
Patrick Leahy
D, VT
Leahy Member Statement 080103
Panel I
Mr.
Robert Armitage
Vice President and General Counsel
Eli Lilly and Company
Washington, DC
Download Testimony
Panel II
The Honorable
Timothy J. Muris, Esq.
Chairman
Federal Trade Commission
Washington, DC
Download Testimony
Mr.
Sheldon T. Bradshaw
Deputy Assistant Attorney General, Office of Legal Counsel
U.S. Department of Justice
Washington, DC
Download Testimony
Mr.
Jon Dudas
Deputy Under Secretary for Intellectual Property, Deputy Director of the United States Patent and Trademark Office
Department of Commerce
Arlington, VA
Download Testimony
Mr.
Dan Troy, Esq.
Chief Counsel for Food and Drugs
Food and Drug Administration
Rockville, MD
Download Testimony
About
The Committee
The Chair
The Ranking Member
Membership
Subcommittees
Committee Rules
Clerkships
Committee Activity
Hearings
Oversight
Legislation
Committee Documents
Nominations
Executive Nominations
Judicial Nominations
Supreme Court
Confirmed Nominations
Latest News
Majority Press
Minority Press
Press Kit
website-search
Site Search